Bio-Rad Laboratories, Inc. (BIO)
381.76
+1.73
(+0.46%)
USD |
NYSE |
Aug 24, 16:00
381.07
-0.69
(-0.18%)
After-Hours: 20:00
Bio-Rad Laboratories EPS Diluted (Quarterly) : 13.85 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.85 |
| March 31, 2026 | -19.55 |
| December 31, 2025 | 26.65 |
| September 30, 2025 | -12.70 |
| June 30, 2025 | 11.67 |
| March 31, 2025 | 2.289 |
| December 31, 2024 | -25.57 |
| September 30, 2024 | 23.34 |
| June 30, 2024 | -76.26 |
| March 31, 2024 | 13.45 |
| December 31, 2023 | 12.14 |
| September 30, 2023 | 3.636 |
| June 30, 2023 | -39.59 |
| March 31, 2023 | 2.318 |
| December 31, 2022 | 27.78 |
| September 30, 2022 | -5.476 |
| June 30, 2022 | -31.05 |
| March 31, 2022 | -112.50 |
| December 31, 2021 | -52.54 |
| September 30, 2021 | 129.96 |
| June 30, 2021 | 30.32 |
| March 31, 2021 | 32.38 |
| December 31, 2020 | 27.81 |
| September 30, 2020 | 43.64 |
| June 30, 2020 | 32.15 |
| Date | Value |
|---|---|
| March 31, 2020 | 22.72 |
| December 31, 2019 | 18.31 |
| September 30, 2019 | -8.676 |
| June 30, 2019 | 19.86 |
| March 31, 2019 | 28.74 |
| December 31, 2018 | -27.88 |
| September 30, 2018 | 8.891 |
| June 30, 2018 | 8.87 |
| March 31, 2018 | 21.77 |
| December 31, 2017 | 2.748 |
| September 30, 2017 | 0.7343 |
| June 30, 2017 | 0.1678 |
| March 31, 2017 | 0.415 |
| December 31, 2016 | -0.70 |
| September 30, 2016 | 0.62 |
| June 30, 2016 | 0.61 |
| March 31, 2016 | 0.42 |
| December 31, 2015 | 1.68 |
| September 30, 2015 | 0.59 |
| June 30, 2015 | 0.97 |
| March 31, 2015 | 0.61 |
| December 31, 2014 | 1.34 |
| September 30, 2014 | 0.39 |
| June 30, 2014 | 1.09 |
| March 31, 2014 | 0.23 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 4.679 |
| Agilent Technologies, Inc. | 1.198 |
| Danaher Corp. | 1.230 |
| Illumina, Inc. | 1.353 |
| Revvity, Inc. | 0.4642 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 371.40M |
| Revenue (Quarterly) | 651.00M |
| Total Expenses (Quarterly) | 279.60M |
| Enterprise Value | 9.958B |
| Gross Profit Margin (Quarterly) | 53.12% |
| Profit Margin (Quarterly) | 57.05% |
| Earnings Yield | 2.16% |
| Operating Earnings Yield | 2.29% |
| Normalized Earnings Yield | 1.680 |